Shenzhen YHLO Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	596.95	407.25	464.97	490.59	1,251	478.85
Short-Term Investments	-	-	182.36	143.6	68.57	-
Trading Asset Securities	65.01	116.23	69.59	76.66	114.16	16.15
Cash & Short-Term Investments	661.96	523.48	716.93	710.85	1,433	495
Cash Growth	-2.23%	-26.98%	0.85%	-50.40%	189.56%	113.03%
Accounts Receivable	592.07	596.1	523.85	414.19	346.38	254.43
Other Receivables	28.39	22.93	54.23	48.11	66.2	21.48
Receivables	620.45	619.03	578.08	462.3	412.58	275.91
Inventory	600.1	601.97	670.77	634.5	569.54	363.81
Other Current Assets	108.07	228.67	45.98	43.08	79.72	43.34
Total Current Assets	1,991	1,973	2,012	1,851	2,495	1,178
Property, Plant & Equipment	1,744	1,761	1,735	1,371	1,044	672.07
Long-Term Investments	266.03	248.65	358.17	260.91	302.82	75.42
Goodwill	5.29	5.29	5.29	5.29	5.29	-
Other Intangible Assets	155.79	161.09	182.88	188.98	210.07	103.78
Long-Term Accounts Receivable	-	-	-	-	-	3.76
Long-Term Deferred Tax Assets	49.28	48.92	44.01	47.68	50.57	16.81
Long-Term Deferred Charges	27.67	27.46	26.97	43.12	36.15	22.87
Other Long-Term Assets	62.7	63.41	51	37.89	69.9	65.05
Total Assets	4,301	4,289	4,415	3,806	4,214	2,138
Accounts Payable	187.95	210.63	213.13	203.81	307.76	137.6
Accrued Expenses	98.62	88.48	164.42	145.99	211.11	54.88
Short-Term Debt	317.7	279.48	292.32	171.07	279.36	150.82
Current Portion of Long-Term Debt	22.87	28.54	23.8	-	-	-
Current Portion of Leases	-	-	1.84	1.07	5.05	4.73
Current Income Taxes Payable	25.09	43.84	4.59	13.27	75.73	12.27
Current Unearned Revenue	136.93	144.89	184.5	183.51	528.61	111.09
Other Current Liabilities	118	128.41	173.11	122.56	126.24	40.79
Total Current Liabilities	907.16	924.27	1,058	841.28	1,534	512.17
Long-Term Debt	597.66	587.83	585.44	381.89	183.9	73.26
Long-Term Leases	0.97	0.07	2.39	3.57	5.24	4.89
Long-Term Unearned Revenue	87.66	84.48	62.52	36.7	29.75	33.25
Long-Term Deferred Tax Liabilities	2.05	2.47	4.54	9.06	15.88	0.02
Other Long-Term Liabilities	2.52	2.28	0.74	-	-	-
Total Liabilities	1,598	1,601	1,713	1,273	1,769	623.59
Common Stock	571.39	571.39	570.27	568.13	567	405
Additional Paid-In Capital	518.73	518.59	480.36	432.24	389.51	525.03
Retained Earnings	1,614	1,596	1,692	1,546	1,447	595.8
Comprehensive Income & Other	9.36	11.7	14.38	13.53	13.84	-0.12
Total Common Equity	2,713	2,697	2,757	2,560	2,417	1,526
Minority Interest	-10.18	-9.96	-55.32	-26.27	28.1	-11.49
Shareholders' Equity	2,703	2,687	2,702	2,534	2,445	1,514
Total Liabilities & Equity	4,301	4,289	4,415	3,806	4,214	2,138
Total Debt	939.2	895.91	905.79	557.6	473.55	233.69
Net Cash (Debt)	-277.25	-372.44	-188.86	153.25	959.74	261.31
Net Cash Growth	-	-	-	-84.03%	267.28%	-
Net Cash Per Share	-0.46	-0.64	-0.33	0.27	1.69	0.48
Filing Date Shares Outstanding	598.36	571.39	570.27	568.13	567	567
Total Common Shares Outstanding	598.36	571.39	570.27	568.13	567	567
Working Capital	1,083	1,049	954.06	1,009	961.27	665.88
Book Value Per Share	4.53	4.72	4.83	4.51	4.26	2.69
Tangible Book Value	2,552	2,531	2,569	2,366	2,202	1,422
Tangible Book Value Per Share	4.26	4.43	4.50	4.16	3.88	2.51
Buildings	-	-	891.92	342.69	322.37	222.47
Machinery	-	-	1,370	1,069	817.66	582.7
Construction In Progress	-	-	168.82	460.54	256.9	96.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.